Consulta farmacêutica ao portador do diabetes mellitus tipo 2

Detalhes bibliográficos
Ano de defesa: 2011
Autor(a) principal: Zubioli, Arnaldo
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Estadual de Maringá
Brasil
Departamento de Farmacologia e Terapêutica
Programa de Pós-Graduação em Ciências Farmacêuticas
UEM
Maringá, PR
Departamento de Farmácia
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: http://repositorio.uem.br:8080/jspui/handle/1/1968
Resumo: In this study the introduction of pharmaceutical consultation in the development of pharmaceutical care in type 2 diabetic patients were evaluated. Fifty patients were selected among patients from the Pharmacy School or People's Pharmacy of State University of Maringá (city of Maringá, Paraná state, Brazil), with fasting glycemia - 140mg/dl or glycated Hemoglobin A1C - 7.0 %. During twelve months the follow-up evaluated drug therapy and its monitoring through the laboratory tests, vital signs, anthropometry and body composition. These procedures were done after the first interview and repeated every 4 months. The results showed a correlation between self-care and glycated hemoglobin A1C, lipid profile and vital signs. The concordance with drug treatment and pharmacological correction of drug related problems (drug's necessity, effectiveness and safety) contributed to these results. After one year, there was an improvement of type 2 diabetes and hypertension (76%), hypercholesterolemia (24%), hypertriglyceridemia (32%) and other comorbidities (24%). Therefore, pharmaceutical consultation is a very important tool to systematize the application of pharmaceutical care to patients with type 2 diabetes by improving self-care behaviors and their relationship with health indicators, with the advantage of its use in other chronic diseases.